echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Faith Medicine's AAV gene therapy is approved for clinical treatment of hemophilia B patients

    Faith Medicine's AAV gene therapy is approved for clinical treatment of hemophilia B patients

    • Last Update: 2021-08-29
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Text|Pharmaceutical Mission Hills

    Recently, the BBM-H901 injection clinical trial application independently developed by Shanghai Xinzhi Pharmaceutical Technology Co.


    Screenshot source: CDE official website

    Public information shows that Faith Medicine was founded in September 2016 and is a high-tech enterprise integrating the research and development, production and clinical application of gene therapy drugs


    BBM-H901 injection is an AAV gene therapy drug developed by Faith Medicine, which aims to introduce human coagulation factor IX (Factor IX, FIX) gene into hemophilia B patients through intravenous administration, thereby improving and maintaining the patient's body for a long time.


    Since 2019, BBM-H901 injection has started clinical research initiated by researchers


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.